VIJAY SONI
Also known as: Vijay Soni
Weill Cornell Medicine, Weill Cornell Medical College, National Institute of Immunology, Birla Institute of Technology and Science-Pilani, Hyderabad Campus, Mohanlal Sukhadia University
Research areas: Medicine · Infectious Diseases · Tuberculosis Research and Epidemiology · Bacterial Genetics and Biotechnology · Antibiotic Resistance in Bacteria
About
With over 13 years of research experience in metabolomics, transcriptomics, chemical biology, and drug discovery and development, I am a passionate and skilled instructor of medicine at Weill Cornell Medicine. I have a Ph.D. in Tuberculosis drug development from the National Institute of Immunology and BITS Pilani, and I have published more than 32 research articles, patents, books, and reviews in this field.
Employment
-
Weill Cornell Medicine Instructor of Microbiology in Medicine2021 - Present
-
Weill Cornell Medical College Postdoctoral Associate2016 - 2021
-
National Institute of Immunology Senior Research Fellow2016 - 2016
-
National Institute of Immunology Senior Research Fellow2010 - 2011
-
National Institute of Immunology Junior Research Fellow2009 - 2010
Education
- 2012 - 2016
-
Birla Institute of Technology and Science-Pilani, Hyderabad Campus PhD2012 - 2016
- 2007 - 2009
- 2003 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (60)
- Untargeted metabolomics reveals organism specific biomarkers of carbapenem resistance in Klebsiella pneumoniae and Escherichia coli Save
- Metabolic rewiring of isoniazid sensitivity in Mycobacterium tuberculosis Save
- Sugar phosphate-mediated inhibition of peptidoglycan precursor synthesis Save
- RNA polymerase-mediated regulation of intrinsic antibiotic resistance and bacterial cell division Save
- Editorial: Metabolomics in bacterial infections Save
- Functional characterization of MMAR_1296 in Mycobacterium marinum and its potential as a vaccine candidate Save
- Sugar phosphate-mediated inhibition of peptidoglycan precursor synthesis Save
- Decoding Serum Metabolic Secrets of Nontuberculous Mycobacterial Pulmonary Disease Save
- Book: Systems Biology and Antimicrobial Drug Resistance Save
- Editorial: Systems biology and antimicrobial drug resistance Save
- Alternative therapeutics to control antimicrobial resistance: a general perspective Save
- The Bacillus subtilis yqgC-sodA operon protects magnesium-dependent enzymes by supporting manganese efflux Save
- TheBacillus subtilis yqgC-sodAoperon protects magnesium-dependent enzymes by supporting manganese efflux Save
- Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance Save
- Antimicrobial Resistance and Factors: An Introduction Save
- Applications of Artificial Intelligence and Machine Learning in Antimicrobial Resistance Study Save
- Future Prospective of Omics-System Biology to Control AMR: Recommendations and Directions Save
- Microbial Metabolomics to Understand Antimicrobial Resistance and Drug Metabolism Save
- Omics-Based Approaches in Developing Treatments Against Antimicrobial Resistance Save
- Gut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapy Save